Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776

IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630

Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967

Disruption of IRS-2 causes type 2 diabetes in mice

Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775

Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study

Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women

Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139

Phosphatidylinositol 3-Kinase Activation Is Required for Insulin Stimulation of pp70 S6 Kinase, DNA Synthesis, and Glucose Transporter Translocation

Cheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062

Signaling pathways in insulin action: molecular targets of insulin resistance

Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939

Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.

Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 911

Genomics and Polycystic Ovary Syndrome (PCOS): The Use of Microarray Analysis to Identify New Candidate Genes

Wood, J. R., & Strauss, J. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-309-7_12

Metabolic Complications of Polycystic Ovary Syndrome

Setji, T. L., & Brown, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_23

Peso ao nascimento e Síndrome dos Ovários Policísticos: mais uma associação tardia dentro da reprogramação fetal?

de Melo, A. S. (2009) · doi:10.11606/d.17.2009.tde-26092013-165328

Elevated Serum Retinol Binding Protein 4 Level in Non-Obese Women with Polycystic Ovary Syndrome

Akbay, E., Gen, R., Muşlu, N., Çayan, F., & Özhan, O. (2011) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2009-16198

Recommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques

Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Gynécologie · doi:10.1016/s0246-1064(08)44358-x

Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos

Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(08)70803-8

Syndrome des ovaires polykystiques en période péripubertaire : polymorphisme clinique, biologique, métabolique et génétique

Trimeche, S., Dieudonne, J.-F. T. D., Jeandel, C., Paris, F., Brum, I. S., Orio, F., & Sultan, C. (2004) · EMC - Gynécologie-obstétrique · doi:10.1016/j.emcgo.2004.10.004

Pathologic Characteristics of Ovarian Hemorrhagic Polycyst in Estrogen Receptor-alpha (ERα) Knockout Mice and Roles of ERα in Hemorrhagic Polycyst

Son, H.-J., Kim, J.-H., Lee, H., Park, M.-J., Kang, D., & Ko, C. J. (2010) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2010.44.4.376

Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care

Samraj, G. P. N., & Kuritzky, L. (2002) · Comprehensive Therapy · doi:10.1007/s12019-002-0030-z

Hormonal regulation of the primate uterus : effects of hormone treatment and lifestyle intervention

Hulchiy, M. (2015) · Figshare

The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease

Reasner, C. A. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-17

Metabolismo de los hidratos de carbono en el síndrome de ovario poliquístico Metabolism of Carbohydrates in the Polycystic Ovary Syndrome

Sabán, M., Soutelo, M. J., & Lutfi, R. J. (2012)

Assessment of the levels of some trace elements in polycystic ovary syndrome and the possible association With insulin resistance.

ORRY, M. M. A.-J. (2017) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.1.b143-151

Dietary management of Polycystic ovary syndrome.

Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

poliquístico,del internista

Rodríguez-Flores, M. (2011)

WOMEN FERTILITY ASSOCIATED WITH END-STAGE CHRONIC RENAL FAILURE (LITERATURE REVIEW)

Литвинов, А. С., & Bisultanova, Z. A. (2017) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2017-21-5-9-13

Polycystic Ovary Syndrome. Androgen excess and insulin resistance in women: Identification of molecular targets to improve glucose homeostasis

Kokosar, M. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Elucidation of regulatory mechanisms revealed by human promoter sequence analysis of genes co-expressed in forskolin-treated theca cells in PCOS

Maitra, C. S. (2013)

The Metabolic Syndrome: 2009

Reasner, C. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-963-5_7

Importance of biological clock epigenetics in the manifestation of polycystic ovary syndrome

Rahman, Z., Bazaz, M. R., Pasam, T., Kumar, M. S., & Dandekar, M. P. (2022) · Biological Sciences · doi:10.55006/biolsciences.2021.1107

Faculty Opinions recommendation of Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice.

Leinwand, L. A. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14267387.15779606

Stringency in polycystic ovary syndrome (PCOS) criteria and application in clinical study recruitmentPreprint

Schneider, C. P., Huddleston, H. G., Masharani, U. B., Mason, A. E., & Frassetto, L. A. (2020) · doi:10.21203/rs.3.rs-24249/v2

Comparing Naltrexone and Metformin Pretreatment for Inducing Ovulation in Patients With Polycystic Ovary Syndrome in Intrauterine Insemination Cycles

Zarei, A., Jahromi, B. N., Madadi, G., Alborzi, M., & Bakhshaei, P. (2022) · Crescent Journal of Medical and Biological Sciences · doi:10.34172/cjmb.2022.28

The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease

Reasner, C. A. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.011

Evaluation of Biochemical and Hematological Parameters in Polycystic Ovarian Syndrome Among Urban College Girls

Sujatha, M. J., Safiya, S., Reeba, & Annambhotla, P. (2022) · International Journal of Zoological Investigations · doi:10.33745/ijzi.2022.v08i0s1.001

Serum Levels of Uric Acid in Females of Polycystic Ovarian Syndrome with and without Insulin Resistance

Riaz, A., Ibrar, F., Fatima, T., Khanam, S., Ashraf, M., & Ghuman, A. A. (2023) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v4i01.502

Polycystic Ovarian Syndrome- Revisited

Najimudeen, M., Myint, M. H., Anisah, J., M, W. S., & M, T. R. (2023) · Scholars International Journal of Obstetrics and Gynecology · doi:10.36348/sijog.2023.v06i03.001

Polycystic ovary syndrome - Effect of acupuncture on insulin resistance and neuroendocrine function

Johansson, J. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Hyperinsulinism, Insulin Resistance and Fertility

Espinós, J. J., & Calaf, J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50025-5

Syndrome des ovaires polykystiques

Hugues, J. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0061-5_17

Additional file 1 of Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome

Zhai, J., Li, S., Hu, M., Di, F., Liu, J., & Du, Y. (2020) · Figshare · doi:10.6084/m9.figshare.12197211

A review of the role of physical activities in managing polycystic ovary syndrome symptoms

Orofino, F., Allibrio, E., Paternò, V., Crescimanno, C., & Pallotti, F. (2026) · Sport Sciences for Health · doi:10.1007/s11332-026-01757-y

Repercussões metabólicas: quais, como e por que investigar?

Soares, J. M., Baracat, M. C. P., & Baracat, E. C. (2021) · Femina · doi:10.61622/0100-7254499202101

Repercussões metabólicas e uso dos medicamentos sensibilizadores da insulina em mulheres com síndrome dos ovários policísticos

Soares, J. M., Maciel, G. A. R., Baracat, M. C. P., & Baracat, E. C. (2019) · Femina · doi:10.61622/0100-7254479201903

Insulin signaling in PCOS/PMOS: molecular insights and clinical implications

Goel, A., Grover, A., & Shekhar, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1955884

Insulin mimetics and non-canonical insulin receptor signaling: mechanisms and disease relevance

Park, J., & Choi, E. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01862-5

Research Progress on the Synergistic Mechanisms of Chinese Herbal Medicine Combined with Metformin in the Treatment of Polycystic Ovary Syndrome with Insulin Resistance Based on the “Kidney-Tonifying and Phlegm-Resolving” Method

庞, 坤. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.16103392

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283

Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome

Corbould, A. M., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166

Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo

Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz‐Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J. R., & Sutherland, C. D. (2008) · Biochemical Journal · doi:10.1042/bj20082176 · Cited by 56

Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment

Højlund, K., Glintborg, D., Andersen, N. R., Birk, J. B., Treebak, J. T., Frøsig, C., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2007) · Diabetes · doi:10.2337/db07-0706 · Cited by 146

Impaired Insulin Activation and Dephosphorylation of Glycogen Synthase in Skeletal Muscle of Women with Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment

Glintborg, D., Højlund, K., Andersen, N. R., Hansen, B. F., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0760 · Cited by 37